Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by Cdninvstron Jan 22, 2010 8:32pm
374 Views
Post# 16710488

Covidien Bought Aspect Medical For A Premium

Covidien Bought Aspect Medical For A PremiumIt's obvious from the following chart that Covidien could have acquired Aspect Medical for less $$$. They certainly didn't lowball on the takeover pps. Have faith that when Nuvo gets swallowed up by Covidien, it will be for a nice premium. Maybe Covidien is waiting for Ranbaxy to get approvals for the 300 million people they are marketing Oxoferin to. Remember that Covidien admitted that they were surprised taken that Pennsaid was approved without more red tape. They were caught flat footed and will need a little extra time to get their ducks in a row before they take out Nuvo. As I've said in the past....lack of news releases from management speaks volumes.


https://www.google.ca/finance?q=NASDAQ%3AASPM
Bullboard Posts